// App-Quantinova.ai

: PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

Researchers

Presenter

  • Nicholas John Van As

Principal Investigators

  • Alison Tree

  • Peter James Ostler

  • William Chu

  • Andrew Loblaw

  • Daniel Ford

  • Shaun P. Tolan

  • Suneil Jain

  • Alexander Stephen Martin

  • John Staffurth

  • Stephanie Brown

  • Stephanie M. Burnett

  • Aileen Duffton

  • Clare Griffin

  • Vicki Hinder

  • Kirsty Morrison

  • Olivia Frances Naismith

  • Emma Hall

Medical Centers

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Mount Vernon Hospital, Dunstable, United Kingdom

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • City Hospital, Cancer Centre Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

  • University of Southern California, Los Angeles, CA

  • Royal Marsden NHS Trust, Sutton, United Kingdom

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multinational

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • NCT01584258

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved